TYRO3 agonist as therapy for glomerular disease

Podocyte injury and loss are key drivers of primary and secondary glomerular diseases, such as focal segmental glomerulosclerosis (FSGS) and diabetic kidney disease (DKD). We previously demonstrated the renoprotective role of protein S (PS) and its cognate tyrosine-protein kinase receptor, TYRO3, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Fang, Cai, Hong, Fu, Jia, Sun, Zeguo, Li, Zhengzhe, Bauman, David, Wang, Lois, Das, Bhaskar, Lee, Kyung, He, John Cijiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870075/
https://www.ncbi.nlm.nih.gov/pubmed/36454644
http://dx.doi.org/10.1172/jci.insight.165207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870075/
https://www.ncbi.nlm.nih.gov/pubmed/36454644
http://dx.doi.org/10.1172/jci.insight.165207

Ejemplares similares